Sofia Karageorgopoulou

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon et al. · Journal of Clinical Oncology · 2023 · 331 citations · Full text

Medicine, Oncology, Pharmacology +12

Responses to SARS-CoV-2 Vaccination in Patients with Cancer (ReCOVer Study): A Prospective Cohort Study of the Hellenic Cooperative Oncology Group

Helena Linardou, Nikolaos Spanakis, Georgia-Angeliki Koliou et al. · Cancers · 2021 · 41 citations · Full text

Veterinary Medicine, Immunology, Oncology +17

Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group

Elena Fountzilas, Georgia-Angeliki Koliou, Athanassios Vozikis et al. · ESMO Open · 2020 · 38 citations · Full text

Medicine, Oncology, Pharmacoeconomics +17

Testicular Function in Poor‐Risk Nonseminomatous Germ Cell Tumors Treated With Methotrexate, Paclitaxel, Ifosfamide, and Cisplatin Combination Chemotherapy

Dimitrios Pectasides, Eirini Pectasides, George Papaxoinis et al. · Journal of Andrology · 2009 · 27 citations

Medicine, Oncology, Pharmacology +16

Concordance between Three Homologous Recombination Deficiency (HRD) Assays in Patients with High-Grade Epithelial Ovarian Cancer

Elena Fountzilas, Kyriaki Papadopoulou, Thomas Chatzikonstantinou et al. · Cancers · 2023 · 22 citations · Full text

Medicine, Oncology, Pathology +12